Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurosci.

Sec. Brain Imaging Methods

Development and Validation of a Predictive Nomogram for Cerebral White Matter Hyperintensities: Insights from a Comprehensive Clinical and Laboratory Analysis

Provisionally accepted
Xiaoying  XuXiaoying Xu1Lijing  WangLijing Wang2Yao  LiYao Li2Yadong  HuYadong Hu2Yajing  ChenYajing Chen2Ye  JiangYe Jiang2Ning  LiNing Li3*
  • 1Baoding No 1 Central Hospital, Baoding, China
  • 2Affiliated Hospital of Hebei University, Baoding, China
  • 3Xiongan Xuanwu Hospital, Baoding, China

The final, formatted version of the article will be published soon.

Background: White matter hyperintensities (WMH) are key imaging markers of cerebral small vessel disease (CSVD), associated with cognitive decline and stroke risk. An accurate predictive model is needed for early risk assessment. Methods: This retrospective study utilized data from 587 patients undergoing cranial magnetic resonance imaging (MRI) at Hebei University's Neurology Department. A predictive model for WMH was developed using a combination of clinical and laboratory parameters through Least Absolute Shrinkage and Selection Operator (LASSO) regression and binary logistic regression analysis. The model's performance was evaluated using Area Under the Receiver Operating Characteristic Curve (AUC-ROC), calibration plots, and Decision Curve Analysis (DCA). Results: Key predictors included age, history of stroke, hypertension, triiodothyronine levels, albumin-globulin ratio, and homocysteine. The nomogram achieved an AUC of 0.783 (95% CI: 0.738–0.829) in the training cohort and 0.762 (95% CI: 0.690–0.834) in the validation cohort. Calibration and DCA confirmed the model's clinical applicability. Conclusion: This study presents a validated nomogram for predicting WMH, integrating clinical and biochemical markers. The model demonstrated robust predictive accuracy and potential for early risk stratification. Future studies should focus on multi-center validation and expanded risk factor inclusion.

Keywords: Cerebral small vessel disease (CSVD), white matter hyperintensities (WMH), PredictiveModeling, Neuroimaging, LASSO regression, nomogram, Risk Assessment

Received: 12 Jun 2025; Accepted: 29 Oct 2025.

Copyright: © 2025 Xu, Wang, Li, Hu, Chen, Jiang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ning Li, li8743@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.